Reuters logo
BRIEF-Incyte announces first patient treated in clinical trial program in graft-versus-host disease
2016年12月30日 / 晚上9点40分 / 10 个月前

BRIEF-Incyte announces first patient treated in clinical trial program in graft-versus-host disease

Dec 30 (Reuters) - Incyte Corp

* Incyte announces first patient treated in pivotal clinical trial program for ruxolitinib (Jakafi) in graft-versus-host disease Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below